why nvax stock is down?
11108
What happened. Shares of Novavax (NASDAQ:NVAX) were down by 10.4% on Wednesday, even though the vaccine maker did not report any news, and the stock market was up today. ... And so investors are less confident that Novavax will make a fortune off its potential COVID-19 vaccine.
1027287
NCC Ncc is falling or rising technical reasons Stock is falling and might fall more. Stock is slowly closing in and getting inside a small range. This happens when a stock is near a support or a resistance.
1465629
(VXX decays heavily over time due to contango and does not generally make for an efficient long-term trading vehicle. Therefore, VXX should only be traded short term and/or should be shorted after spikes in volatility.)
329005
The broader indexes fell due to uncertainty amid COVID-19. On April 10, Nvidia stock fell 1.5% and closed at $262.95 with a market cap of $160.9 billion. The stock price has risen 2.9% in the trailing five-day period, while it has risen 38.9% in the trailing 12-month period.
85987
The Kwality stock fell in trade on Wednesday after the firm deferred a decision on buyback of securities, bonus issue of securities and payment of interim dividend in a board meeting. The stock of dairy products manufacturer was trading 4.84% lower at 20.65 level, a five-year low on BSE.
1060837
The share price of Glenmark Pharmaceuticals declined over 5 percent after the US Department of Justice charged the company with conspiring to fix prices for generic drugs. The stock plunged 5.08 percent to an intraday low of Rs 427.30 apiece on the BSE.
862889
There are three main reasons for the stock price to fall. First is the poor performance of the company in the quarter ending June 2015. All the companies in the group reported poor top line growth. In fact Amtek Auto posted a loss after a marginally positive operating profit.
748778
Specifically, DexCom's stock was down by an eye-catching 13.8% as of 10:37 a.m. EDT Monday morning. DexCom, along with most other U.S. stocks, is reacting negatively to both the Federal Reserve's emergency rate cut over the weekend and the fallout resulting from the continued spread of COVID-19 across the globe.
266449
The S&P 500 declined by 7.6% on Monday, March 9, and it has fallen by 25% since February 1, after the global health emergency was declared by the WHO. Merck's stock decline of 13% since February 1 compares with 19% decline for Pfizer over the same period.
760582
This is because Dilip Buildcon's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.
120574
The Nufarm Limited (ASX: NUF) share price has dropped almost 9% to $5.01. This appears to have been driven by a broker note out of Macquarie this morning. According to the note, the broker has downgraded Nufarm's shares to an underperform rating with a $4.85 price target.
481240
NMC Health stock suspended, dropped from FTSE 100 after share price slump. The healthcare operator saw its stock suspended last week and relegated from the FTSE 100 after its share price fell by more than 60% following an independent review that revealed potential financial discrepancies.
1465572
While Arista Networks' stock is down by roughly 10% from its February 2020 highs due to the broader market sell-off, caused by the Coronavirus pandemic, it is also down by about 9% from levels seen in early 2018, a little over 2 years ago, due to weak guidance in recent quarters amid concerns about the spending of its ...
1341507
The financial health and growth prospects of CNQ, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
536671
What happened. Shares of Biogen (NASDAQ:BIIB) were sinking 10.5% as of 10:59 a.m. EDT on Wednesday. The big drop came after the biotech announced in its first-quarter earnings update that it was delaying the filing for U.S. regulatory approval of aducanumab in treating Alzheimer's disease.
1189317
Our Ai stock analyst implies that there will be a negative trend in the future and the MJNA shares are not a good investment for making money. Since this share has a negative outlook we recommend looking for other projects instead to build a portfolio.
653800
TGOD Stock: Why So Bearish? ... While a rise of 28% is undoubtedly positive, a significant problem with "cash-burning" remains, and this is likely why TGOD stock has dropped significantly in recent months. >> Aphria Stock Consolidates as Investors are Undecided. The company reported a net loss of $14.1 million in Q1.